Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept + Methotrexate in Polyarticular JRA
NCT03781375Phase 3Terminated
- Sponsor
- Amgen
- Start
- Aug 2000
- Primary completion
- Jun 2002
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of etanercept in juvenile idiopathic arthritis (JIA), sponsored by Amgen. Started Aug 2000; status: terminated.
02
Drugs
etanercept
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT03781375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781375.